Prelude Capital Management, LLC Axogen, Inc. Transaction History

Prelude Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $1,807 - $2,628	240 Added 0.94%	25,729 $243,000
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $240,616 - $333,651	25,489 New	25,489 $254,000
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $3,450 - $5,388	-300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.35 - $10.81 $1,470 - $2,162	200 Added 200.0%	300 $3,000
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $838 - $1,734	100 New	100 $1,000
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $77,142 - $128,340	-6,900 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $27,807 - $47,058	-2,300 Reduced 25.0%	6,900 $86,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $33,300 - $45,846	1,800 Added 24.32%	9,200 $182,000
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $195,966 - $296,630	-13,404 Reduced 64.43%	7,400 $156,000
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $69,744 - $156,098	4,081 Added 24.4%	20,804 $425,000
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $23,834 - $39,130	700 Added 4.37%	16,723 $616,000
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $599,511 - $870,660	-16,584 Reduced 50.86%	16,023 $805,000
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $45,652 - $75,307	-1,871 Reduced 5.43%	32,607 $1.19 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $210,715 - $325,754	11,390 Added 49.33%	34,478 $976,000
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $338,239 - $446,752	23,088	23,088 $447,000

178

36.5M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $745M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.